论文部分内容阅读
目的探讨盐酸氨溴索雾化吸入预防脑卒中患者发生坠积性肺炎的临床疗效。方法选取北京市朝阳区双桥医院住院的脑卒中患者100例,随机分为治疗组和对照组,每组50例。在对两组患者给予脑卒中的基础治疗和基础护理措施外,治疗组还给予盐酸氨溴索30 mg+生理盐水4 ml超声雾化吸入,2次/d,10 d为1个疗程。观察两组并发坠积性肺炎情况及住院时间。采用SPSS13.0统计软件进行统计分析,计量资料用均数±标准差(±s)表示,采用t检验,计数资料用率(%)表示,采用χ~2检验,P<0.05表示差异有统计学意义。结果治疗组脑卒中患者中发生坠积性肺炎的比例为4.00%,对照组患者发生坠积性肺炎的比例为18.00%,差异有统计学意义(P<0.05);治疗组脑卒中患者平均住院时间明显低于对照组,分别为(13.3±5.2)d和(20.2±6.4)d,差异有统计学意义(P<0.05)。两组患者在治疗过程中,均未出现明显的身体不适,两组不良反应发生率比较,差异无统计学意义(P>0.05)。结论盐酸氨溴索雾化吸入预防脑卒中患者发生坠积性肺炎临床疗效显著。
Objective To investigate the clinical efficacy of inhalation of ambroxol hydrochloride in the prevention of hypostatic pneumonia in stroke patients. Methods A total of 100 stroke patients admitted to Shuangqiao Hospital of Chaoyang District in Beijing were randomly divided into treatment group and control group, with 50 cases in each group. In the two groups of patients given basic treatment of stroke and basic nursing measures, the treatment group was given ambroxol hydrochloride 30 mg + saline 4 ml inhalation, 2 times / d, 10 d for a course of treatment. The incidence of hypostatic pneumonia and hospital stay were observed in both groups. SPSS13.0 statistical software was used for statistical analysis. The measurement data were expressed as mean ± standard deviation (± s), t test was used, and the count data (%) was used. Chi-square test was used. P <0.05 means difference Statistical significance. Results The incidence of hypostatic pneumonia was 4.00% in the stroke patients and 18.00% in the control group, the difference was statistically significant (P <0.05). The average hospitalization rate of stroke patients in the treatment group The time was significantly lower than that of the control group (13.3 ± 5.2) d and (20.2 ± 6.4) d, respectively. The difference was statistically significant (P <0.05). No significant physical discomfort occurred in both groups during the course of treatment. There was no significant difference in the incidence of adverse reactions between the two groups (P> 0.05). Conclusions Ambroxol Hydrochloride inhalation is effective in preventing stroke due to hypostatic pneumonia.